ArticleBone marrow transplantation2025

Early administration of selected CD34 peripheral blood stem cell following bone marrow transplantation to prevent graft rejection: experience in haploidentical transplant for sickle cell disease.

Clara Barthélemy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.